Cargando…

Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies

Endometrial cancer (EC) is one of the most common malignancies of the female reproductive organs. The most characteristic feature of EC is the frequent association with metabolic disorders. However, the components of these disorders that are involved in carcinogenesis remain unclear. Accumulating ep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyo, Satoru, Nakayama, Kentaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504460/ https://www.ncbi.nlm.nih.gov/pubmed/32842547 http://dx.doi.org/10.3390/ijms21176073

Ejemplares similares

Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status
por: Sawada, Kiyoka, et al.
Publicado: (2023)

Dysregulated PI3K Signaling in B Cells of CVID Patients
por: Harder, Ina, et al.
Publicado: (2022)

The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies
por: Kyo, Satoru, et al.
Publicado: (2019)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
por: Massihnia, Daniela, et al.
Publicado: (2016)

Efficacy of microwave ablation for the treatment of endometrial carcinoma: A report of 3 cases
por: NAKAMURA, KOHEI, et al.
Publicado: (2016)

Shedding light on ethylene metabolism in higher plants
por: Rodrigues, Maria A., et al.
Publicado: (2014)

Shedding light on therapeutics in alopecia and their relevance to COVID-19
por: Fagan, Nicole, et al.
Publicado: (2021)

Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
por: Nakayama, Kentaro, et al.
Publicado: (2012)

Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023)

Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study
por: Nakamura, Kohei, et al.
Publicado: (2017)

Genomics Sheds Light on Metabolism of Cryptic Marine Microbes
por: Gross, Liza
Publicado: (2006)

Shedding light on light pollution
por: The Lancet Regional Health – Europe
Publicado: (2023)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

An Overview of Endometrial Cancer with Novel Therapeutic Strategies
por: Kuhn, Theresa M., et al.
Publicado: (2023)

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
por: You, Hongmei, et al.
Publicado: (2022)

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
por: Hua, Yu, et al.
Publicado: (2023)

Ecogenomics sheds light on diverse lifestyle strategies in freshwater CPR
por: Chiriac, Maria-Cecilia, et al.
Publicado: (2022)

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
por: NAKAYAMA, KENTARO, et al.
Publicado: (2015)

The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy
por: Ishikawa, Masako, et al.
Publicado: (2023)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

Protons shedding light
Publicado: (1979)

Shedding light on CERN
Publicado: (1995)

Shedding Light on Adaptation
por: Hurley, James B.
Publicado: (2002)

Shedding Light On Cones
por: Knox, Barry E., et al.
Publicado: (2006)

Shedding light on the restart
por: Fusi, Franco, et al.
Publicado: (2020)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Reduce, reuse, and recycle: Shedding light on shedding cells
por: Croitoru, Ken, et al.
Publicado: (1993)

Drugging PI3K in cancer: refining targets and therapeutic strategies
por: Yap, Timothy A, et al.
Publicado: (2015)

Pathological findings in the endometrium after microwave endometrial ablation
por: Nakayama, Kentaro, et al.
Publicado: (2020)

Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
por: Pavlidou, Athanasia, et al.
Publicado: (2014)

Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer
por: Nakayama, Naomi, et al.
Publicado: (2022)

Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer
por: Wang, Yizi, et al.
Publicado: (2019)

TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway
por: You, Fang, et al.
Publicado: (2022)

Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer
por: Ma, Liangjian, et al.
Publicado: (2023)

High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer
por: Slattery, Martha L., et al.
Publicado: (2017)

Cancer‐associated mutations in normal human endometrium: Surprise or expected?
por: Kyo, Satoru, et al.
Publicado: (2020)

Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies?
por: Hartsell, Emily M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_df45ejvn4qssgm8oc5fc36l884